Guillet JG - Search Results

1

Passive but not active CD8+ T cell-based immunotherapy interferes with liver tumor progression in a transgenic mouse model.

Romieu R, Baratin M, Kayibanda M, Lacabanne V, Ziol M, Guillet JG, Viguier M. Romieu R, et al. Among authors: guillet jg. J Immunol. 1998 Nov 15;161(10):5133-7. J Immunol. 1998. PMID: 9820481

2

A wild-type p53 cytotoxic T cell epitope is presented by mouse hepatocarcinoma cells.

Lacabanne V, Viguier M, Guillet JG, Choppin J. Lacabanne V, et al. Among authors: guillet jg. Eur J Immunol. 1996 Nov;26(11):2635-9. doi: 10.1002/eji.1830261114. Eur J Immunol. 1996. PMID: 8921949

3

Critical stages of tumor growth regulation in transgenic mice harboring a hepatocellular carcinoma revealed by distinct patterns of tumor necrosis factor-alpha and transforming growth factor-beta mRNA production.

Romieu R, Lacabanne V, Kayibanda M, Antoine B, Bennoun M, Chouaib S, Guillet JG, Viguier M. Romieu R, et al. Among authors: guillet jg. Int Immunol. 1997 Oct;9(10):1405-13. doi: 10.1093/intimm/9.10.1405. Int Immunol. 1997. PMID: 9352345

4

Differential presentation of endogenously processed cytotoxic T lymphocyte epitopes by mouse hepatocarcinoma cell lines induced by SV40 large T antigen.

Lacabanne V, Viguier M, Romieu R, Kayibanda M, Connan F, Sermet S, Antoine B, Guillet JG, Choppin J. Lacabanne V, et al. Among authors: guillet jg. Int Immunol. 1998 Apr;10(4):463-72. doi: 10.1093/intimm/10.4.463. Int Immunol. 1998. PMID: 9620602

5

IFN-gamma-secreting Th cells regulate both the frequency and avidity of epitope-specific CD8+ T lymphocytes induced by peptide immunization: an ex vivo analysis.

Romieu R, Baratin M, Kayibanda M, Guillet JG, Viguier M. Romieu R, et al. Among authors: guillet jg. Int Immunol. 1998 Sep;10(9):1273-9. doi: 10.1093/intimm/10.9.1273. Int Immunol. 1998. PMID: 9786426

6

In vivo T helper cell response to retro-inverso peptidomimetics.

Mézière C, Viguier M, Dumortier H, Lo-Man R, Leclerc C, Guillet JG, Briand JP, Muller S. Mézière C, et al. Among authors: guillet jg. J Immunol. 1997 Oct 1;159(7):3230-7. J Immunol. 1997. PMID: 9317121

7

Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas.

Gnjatic S, Cai Z, Viguier M, Chouaib S, Guillet JG, Choppin J. Gnjatic S, et al. Among authors: guillet jg. J Immunol. 1998 Jan 1;160(1):328-33. J Immunol. 1998. PMID: 9551988

8

Does preventive vaccination with engineered tumor cells work in cancer-prone transgenic mice?

Morel A, de La Coste A, Fernandez N, Berson A, Kaybanda M, Molina T, Briand P, Haddada H, Guillet JG, Antoine B, Viguier M, Kahn A. Morel A, et al. Among authors: guillet jg. Cancer Gene Ther. 1998 Mar-Apr;5(2):92-100. Cancer Gene Ther. 1998. PMID: 9570300

9

Regression of primary hepatocarcinoma in cancer-prone transgenic mice by local interferon-gamma delivery is associated with macrophages recruitment and nitric oxide production.

Baratin M, Ziol M, Romieu R, Kayibanda M, Gouilleux F, Briand P, Leroy P, Haddada H, Rénia L, Viguier M, Guillet JG. Baratin M, et al. Among authors: guillet jg. Cancer Gene Ther. 2001 Mar;8(3):193-202. doi: 10.1038/sj.cgt.7700285. Cancer Gene Ther. 2001. PMID: 11332990

10

Mutations in residue 61 of H-Ras p21 protein influence MHC class II presentation.

Ngo-Giang-Huong N, Kayibanda M, Deprez B, Levy JP, Guillet JG, Tilkin AF. Ngo-Giang-Huong N, et al. Among authors: guillet jg. Int Immunol. 1995 Feb;7(2):269-75. doi: 10.1093/intimm/7.2.269. Int Immunol. 1995. PMID: 7734422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters